did not find a difference between T2D patients and controls, both living with obesity, in the ratio of jejunal GLP‐1 and chromogranin positive cells but did not report numbers of GLP‐1 positive cells (Palha et al., 2018). This evidence concerns the gene GCG and Obesity.